24Jul/13

Genentech's Obinutuzumab (GA101) Delayed Disease Progression Longer … – DailyFinance

Genentech’s Obinutuzumab (GA101) Delayed Disease Progression Longer
DailyFinance
monitoring committee determined that the study met its primary endpoint showing that GA101 plus chlorambucil helped people live significantly longer without their disease worsening (progression-free survival; PFS) compared to Rituxan® (rituximab
Roche antibody tops Rituxan in blood cancer CLLPMLiVE
Genentech Trumpets Phase III Results for CLL CandidateGenetic Engineering News

all 11 news articles »

24Jul/13

Getting the lead out, literally: U.S. Army plans switch to 'green' bullets – Daily Caller

Getting the lead out, literally: U.S. Army plans switch to ‘green’ bullets
Daily Caller
The U.S. Army is taking the expression “get the lead out” quite literally and switching to lead-free, environmentally-friendly bullets. The Army’s Picatinny Arsenal is working on a “green” version of the M80A1 7.62 mm bullet, which troops are supposed